Rafferty Asset Management
SANA icon

Rafferty Asset Management’s Sana Biotechnology SANA Stock Holding History

Rafferty Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Sell
196,731
-156,851
-44% -$505K ﹤0.01% 844
2026
Q1 		$1.02M Buy
353,582
+79,420
+29% +$313K ﹤0.01% 767
2025
Q4 		$1.12M Buy
274,162
+6,177
+2% +$27.7K ﹤0.01% 778
2025
Q3 		$951K Buy
+267,985
New +$969K ﹤0.01% 802
2025
Q2 		– Sell
-195,135
Closed -$328K – 1101
2025
Q1 		$328K Sell
195,135
-118,716
-38% -$332K ﹤0.01% 938
2024
Q4 		$512K Sell
313,851
-10,680
-3% -$31.8K ﹤0.01% 907
2024
Q3 		$1.35M Sell
324,531
-15,899
-5% -$83.5K ﹤0.01% 729
2024
Q2 		$1.86M Sell
340,430
-155,502
-31% -$1.24M 0.01% 667
2024
Q1 		$4.96M Buy
495,932
+58,318
+13% +$437K 0.02% 477
2023
Q4 		$1.79M Buy
437,614
+112,732
+35% +$415K 0.01% 699
2023
Q3 		$1.26M Sell
324,882
-10,901
-3% -$58.6K 0.01% 731
2023
Q2 		$2M Sell
335,783
-72,462
-18% -$418K 0.01% 643
2023
Q1 		$1.33M Sell
408,245
-103,480
-20% -$413K 0.01% 723
2022
Q4 		$2.02M Buy
511,725
+82,559
+19% +$404K 0.02% 574
2022
Q3 		$2.58M Buy
429,166
+58,859
+16% +$425K 0.03% 455
2022
Q2 		$2.38M Sell
370,307
-114,625
-24% -$730K 0.02% 429
2022
Q1 		$4.01M Buy
484,932
+287,779
+146% +$2.33M 0.02% 430
2021
Q4 		$3.05M Buy
197,153
+124,729
+172% +$2.4M 0.02% 535
2021
Q3 		$1.63M Sell
72,424
-14,876
-17% -$312K 0.01% 688
2021
Q2 		$1.72M Buy
+87,300
New +$1.98M 0.01% 732

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Rafferty Asset Management's SANA Position: Q2 2026 in Review

Rafferty Asset Management reduced its Sana Biotechnology (SANA) stake by 44% in Q2 2026, selling an estimated $505K and leaving 196,731 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Rafferty Asset Management first reported a position in SANA in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.96M in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Rafferty Asset Management held 196,731 shares of Sana Biotechnology worth $687K as of Q2 2026.
  • Rafferty Asset Management sold 156,851 Sana Biotechnology shares in Q2 2026, an estimated $505K.
  • Sana Biotechnology made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #844 holding.
  • Rafferty Asset Management first reported a position in Sana Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • Rafferty Asset Management's Sana Biotechnology position peaked at $4.96M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.